As regulatory expectations evolve across FDA and EMA frameworks, organizations are embracing harmonized approaches, digital risk minimization tools, and global strategies to...

This article explores five structural levers that help sponsors reduce hidden operational friction and design adaptive operating models that sustain execution as priorities evolve.

Data isn’t enough, and impact comes from translation. In this webinar, learn how to turn clinical evidence into actionable insights and bridge the gap between publications and...

In this podcast, discover practical AI strategies for small biopharma, from commercial analytics and automation to responsible governance and patient access.

Dr. Samer Al Hadidi discusses how MRD is reshaping multiple myeloma drug development, FDA surrogate endpoints and treatment strategy in this ASCO 2026 podcast.

Can artificial intelligence predict drug resistance before it develops? Explore how AI, protein modeling and predictive biology are reshaping oncology drug discovery and precision...